Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland

INTRODUCTION: In most patients with type 2 diabetes mellitus (T2DM) and progressive beta-cell insufficiency, insulin therapy is required to achieve sufficient glycemic control. However, insulin therapy may lead to weight gain and increasing risk of hypoglycemia. Glucagon-like peptide-1 receptor agon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipowsky, Christof, Sze, Lisa, Krull, Ina, Brändle, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374072/
https://www.ncbi.nlm.nih.gov/pubmed/25576400
http://dx.doi.org/10.1007/s13300-014-0093-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374072/
https://www.ncbi.nlm.nih.gov/pubmed/25576400
http://dx.doi.org/10.1007/s13300-014-0093-8

Ejemplares similares